Phase I: Safety and Efficacy of an Injectable Follistatin Plasmid Gene Therapy in Humans
Clinical trial NCT06411366 · COMPLETED
Trial details
- NCT number
- NCT06411366
- Sponsor
- Minicircle
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-18
- Primary completion
- 2023-08-31
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.